Remote Ischemic Conditioning: The Commercial Market: LifeCuff Perspective
Related Experiment Video
Updated: Aug 17, 2026
Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia
Published on: May 9, 2013
Kirk N Garratt1, Boris Leschinsky2
11 Center for Heart and Vascular Health, Christiana Care Health System, Newark, DE, USA.
Abstract:
Although remote ischemic conditioning promises significant benefit to patients with a variety of acute and chronic illnesses, development of automated, clinically applicable devices has been slow. At least 3 small companies have launched efforts to develop useful tools intended for sale in European and North American markets. The market challenges and opportunities linked to the development of a cost-effective, reliable, and clinically effective device for the application of remote ischemic conditioning are presented in this article.
